Completion Percentage Outdoors1 Kurt Warner 72

In 10 career games against the Cowboys, Eli Manning has thrown 18 touchdown passes with 11 interceptions. From the 8: Did you know...That when the Colts, Texans, Patriots, Bengals, Cowboys, and Chargers have a turnover differential of plus-one, they’re a combined 19-2 on the seasonThe only two losses come from the Texans and Patriots.In addition, the Texans are 1-4 this season when they post a minus-one turnover differential. From the 7: Start ‘EmMichael Crabtree Wide Receiver San Francisco 49ersHe’s averaging just 7.3 targets and 57.6 yards per game this season, but Crabtree is an excellent WR3 option in Week 13 due to a very favorable matchup with the Seattle Seahawks.Seattle has been exposed at will through the air and is giving up an average of 238.1 yards per game (25th). In addition, the Seahawks have been torched for 25.7 fantasy points per week by opposing wide receivers (30th).Look for Crabtree to produce some solid numbers in Week 13. From the 6: Get out of their way!Here are the top five running backs for each of the following statistical categories:Broken Tackles: Michael Turner (21), Steven Jackson (19), Chris Johnson (17), DeAngelo Williams (17), Maurice Jones-Drew (16).Yards After Contact: Chris Johnson (749), Steven Jackson (627), Adrian Peterson (604), DeAngelo Williams (582), Maurice Jones-Drew (579).Fourth-Quarter Rushing: Chris Johnson (325), Adrian Peterson (309), Ryan Grant (280), Thomas Jones (280), Marion Barber (245).Is it any surprise that the top fantasy running back through three weeks (Chris Johnson) is listed in all three categories From the 5: Sit ‘EmChris Chambers Wide Receiver Kansas City ChiefsYes, Chambers has been effective since joining the Chiefs in Week Nine. The former San Diego Charger has caught 17 passes for 319 yards and three touchdowns in four games since coming to Kansas City.But there are two big reasons you should leave him on the bench this weekend: cornerback Champ Bailey and the Denver pass defense.Now that he’s healthy, Bailey has been very difficult to beat this season. Add in the fact that the Broncos are allowing just 17.0 fantasy points per week to opposing wide receivers (sixth), and you’ve got a Week 13 matchup that offers very little promise. From the 4: Drop some knowledge on meI can choose two of the following three running backs to start in a standard-scoring, 10-team league this weekend:1 Chris Johnson (at Indianapolis)2 Ray Rice (at Green Bay, Monday night)3 Rashard Mendenhall (vs. Oakland)Whom do I sit From the 3: Interceptions happen outsideCompletion Percentage: Indoors1 Drew Brees: 72.32 Brett Favre: 71.03 Peyton Manning: 68.94 Aaron Rodgers: 67.75. Jason Campbell: 66.0These five quarterbacks have combined to throw 63 touchdowns with just six interceptions indoors this season.Completion Percentage: Outdoors1 Kurt Warner: 72.62 Peyton Manning: 71.33 Matt Schaub: 70.04 Ben Roethlisberger: 68.25. Tom Brady: 66.4These five quarterbacks have combined to throw 65 touchdowns with 28 interceptions outdoors this season. From the 2: You make the callIn the Game Day fantasy live chat last Sunday, we started talking about which former NFL running back Chris Johnson plays like the most.While his style is completely unique, if you had to compare Johnson to a former NFL great, who would it beMy choice was Bo Jackson.

Other suggestions were Gale Sayers, Barry Sanders, and Marcus Allen.What say you, NFP Nation From the 1: Another Week 13 WinnerThis one comes from the world of college football, as the Tipper is taking...CINCINNATI BEARCATS -2.5 vs. Pittsburgh PanthersWhy I’ve been on Cincinnati all year. The Panthers folded last week to West Virginia, so there’s no chance they prevent the Bearcats from going undefeated. Enjoy the games this weekend!Hit me up on Twitter: JoeFortenbaugh. RESEARCH TRIANGLE PARK, NC, Jan 07 (MARKET WIRE) Recessionary times put tremendous pressure on everyone consumers,companies, governments to spend less. All spending is scrutinized.Even the seemingly recession-proof pharmaceutical industry cannot escapethis type of scrutiny.For example, Celgene's multiple myeloma drug, Revlimid, has drawn muchcriticism for its $260 per pill price tag, which equates to more than$90,000 per year to treat a single patient.

Even in times of growth,pharmaceutical manufacturers struggle to justify such costs forprescription drugs to consumers and insurers. In the midst of the currentrecession, payor groups are turning up the heat on big pharma to delivermore robust pharmacoeconomic and quality-of-life data as a condition offormulary access and reimbursement approval, according to a new report,"Outcomes-Based Pharmaceutical Pricing: Meeting Stakeholder Needs"( http://), from Cutting Edge Information."Governments and third-party payors are requiring drug makers to delivermore robust health outcomes data to inform their reimbursementdecision-making processes," says Elio Evangelista, Cutting EdgeInformation research manager. The case of Revlimidmay not have helped matters either; it has definitely become a two-waystreet in which payor groups are pushing back to get proof that new drugsdeliver marked improvements over existing products."A detailed health outcomes analysis can be one of the most convincing waysof proving a drug's effectiveness. "Outcomes-Based Pharmaceutical Pricing:Meeting Stakeholder Needs" offers an in-depth look at health outcomesstudies. Loaded with primary and secondary research, the report offersguidelines and timelines to help any company perform the best healthoutcomes study possible. Download a free brochure at http:// report contains 400 metrics, and data focus on pricing teams'structures, phase-by-phase pricing processes and methodology, and spendingand staffing resources.